BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ong CWM, Migliori GB, Raviglione M, MacGregor-Skinner G, Sotgiu G, Alffenaar JW, Tiberi S, Adlhoch C, Alonzi T, Archuleta S, Brusin S, Cambau E, Capobianchi MR, Castilletti C, Centis R, Cirillo DM, D'Ambrosio L, Delogu G, Esposito SMR, Figueroa J, Friedland JS, Ho BCH, Ippolito G, Jankovic M, Kim HY, Rosales Klintz S, Ködmön C, Lalle E, Leo YS, Leung CC, Märtson AG, Melazzini MG, Najafi Fard S, Penttinen P, Petrone L, Petruccioli E, Pontali E, Saderi L, Santin M, Spanevello A, van Crevel R, van der Werf MJ, Visca D, Viveiros M, Zellweger JP, Zumla A, Goletti D. Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC). Eur Respir J 2020;56:2001727. [PMID: 32586885 DOI: 10.1183/13993003.01727-2020] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Esposito S, Neglia C, Affanni P, Colucci ME, Argentiero A, Veronesi L, Messina G, Deolmi M, Principi N; Crown Study Group. Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19. Front Public Health 2021;9:628098. [PMID: 34249830 DOI: 10.3389/fpubh.2021.628098] [Reference Citation Analysis]
2 Petruccioli E, Najafi Fard S, Navarra A, Petrone L, Vanini V, Cuzzi G, Gualano G, Pierelli L, Bertoletti A, Nicastri E, Palmieri F, Ippolito G, Goletti D. Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection. J Transl Med 2021;19:272. [PMID: 34174875 DOI: 10.1186/s12967-021-02938-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Rana R, Tripathi A, Kumar N, Ganguly NK. A Comprehensive Overview on COVID-19: Future Perspectives. Front Cell Infect Microbiol 2021;11:744903. [PMID: 34595136 DOI: 10.3389/fcimb.2021.744903] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Migliori GB, Ong CWM, Petrone L, D'Ambrosio L, Centis R, Goletti D. The definition of tuberculosis infection based on the spectrum of tuberculosis disease. Breathe (Sheff) 2021;17:210079. [PMID: 35035549 DOI: 10.1183/20734735.0079-2021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Torre A, Aliberti S, Castellotti PF, Cirillo DM, Grisolia A, Mangioni D, Marchetti G, Rossotti R, Santus P, Besozzi G, Villa S, Codecasa LR; Milan TB-COVID-19 study group. Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy. Respir Med 2020;175:106204. [PMID: 33186846 DOI: 10.1016/j.rmed.2020.106204] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Migliori GB, Visca D, van den Boom M, Tiberi S, Silva DR, Centis R, D'Ambrosio L, Thomas T, Pontali E, Saderi L, Schaaf HS, Sotgiu G; contributing members of the Global Tuberculosis Network. Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence. Pulmonology 2021;27:248-56. [PMID: 33547028 DOI: 10.1016/j.pulmoe.2020.12.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Fronteira I, Sidat M, Magalhães JP, de Barros FPC, Delgado AP, Correia T, Daniel-Ribeiro CT, Ferrinho P. The SARS-CoV-2 pandemic: A syndemic perspective. One Health 2021;12:100228. [PMID: 33614885 DOI: 10.1016/j.onehlt.2021.100228] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
8 Chiang CY, Islam T, Xu C, Chinnayah T, Garfin AMC, Rahevar K, Raviglione M. The impact of COVID-19 and the restoration of tuberculosis services in the Western Pacific Region. Eur Respir J 2020;56:2003054. [PMID: 32978310 DOI: 10.1183/13993003.03054-2020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
9 Migliori GB, Marx FM, Ambrosino N, Zampogna E, Schaaf HS, van der Zalm MM, Allwood B, Byrne AL, Mortimer K, Wallis RS, Fox GJ, Leung CC, Chakaya JM, Seaworth B, Rachow A, Marais BJ, Furin J, Akkerman OW, Al Yaquobi F, Amaral AFS, Borisov S, Caminero JA, Carvalho ACC, Chesov D, Codecasa LR, Teixeira RC, Dalcolmo MP, Datta S, Dinh-Xuan AT, Duarte R, Evans CA, García-García JM, Günther G, Hoddinott G, Huddart S, Ivanova O, Laniado-Laborín R, Manga S, Manika K, Mariandyshev A, Mello FCQ, Mpagama SG, Muñoz-Torrico M, Nahid P, Ong CWM, Palmero DJ, Piubello A, Pontali E, Silva DR, Singla R, Spanevello A, Tiberi S, Udwadia ZF, Vitacca M, Centis R, D Ambrosio L, Sotgiu G, Lange C, Visca D. Clinical standards for the assessment, management and rehabilitation of post-TB lung disease. Int J Tuberc Lung Dis 2021;25:797-813. [PMID: 34615577 DOI: 10.5588/ijtld.21.0425] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Sundah NR, Natalia A, Liu Y, Ho NRY, Zhao H, Chen Y, Miow QH, Wang Y, Beh DLL, Chew KL, Chan D, Tambyah PA, Ong CWM, Shao H. Catalytic amplification by transition-state molecular switches for direct and sensitive detection of SARS-CoV-2. Sci Adv 2021;7:eabe5940. [PMID: 33731349 DOI: 10.1126/sciadv.abe5940] [Reference Citation Analysis]
11 Petrone L, Petruccioli E, Vanini V, Cuzzi G, Najafi Fard S, Alonzi T, Castilletti C, Palmieri F, Gualano G, Vittozzi P, Nicastri E, Lepore L, Antinori A, Vergori A, Caccamo N, Cantini F, Girardi E, Ippolito G, Grifoni A, Goletti D. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients. Clin Microbiol Infect 2021;27:286.e7-286.e13. [PMID: 33045370 DOI: 10.1016/j.cmi.2020.09.051] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 14.0] [Reference Citation Analysis]
12 Magro P, Formenti B, Marchese V, Gulletta M, Tomasoni LR, Caligaris S, Castelli F, Matteelli A. Impact of the SARS-CoV-2 epidemic on tuberculosis treatment outcome in Northern Italy. Eur Respir J 2020;56:2002665. [PMID: 32703780 DOI: 10.1183/13993003.02665-2020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
13 Mohr-Holland E, Hacking D, Daniels J, Scott V, Mudaly V, Furin J, Pfaff C, Reuter A. Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19. Int J Tuberc Lung Dis 2021;25:772-5. [PMID: 34802503 DOI: 10.5588/ijtld.21.0340] [Reference Citation Analysis]
14 Nikolayevskyy V, Holicka Y, van Soolingen D, van der Werf MJ, Ködmön C, Surkova E, Hillemann D, Groenheit R, Cirillo D; ERLTB-Net-2 study participants. Impact of the COVID-19 pandemic on tuberculosis laboratory services in Europe. Eur Respir J 2021;57:2003890. [PMID: 33184119 DOI: 10.1183/13993003.03890-2020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
15 Keddy KH, Migliori GB, Van Der Walt M. Developing health policies in patients presenting with SARS-CoV-2: consider tuberculosis. Lancet Glob Health 2020;8:e1357-8. [PMID: 33069299 DOI: 10.1016/S2214-109X(20)30413-7] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Rodrigues I, Aguiar A, Migliori GB, Duarte R. Impact of the COVID-19 pandemic on tuberculosis services. Pulmonology 2022. [DOI: 10.1016/j.pulmoe.2022.01.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Schiza V, Kruse M, Xiao Y, Kar S, Lovejoy K, Wrighton-Smith P, Tattersall A. Impact of the COVID-19 pandemic on TB infection testing. Int J Tuberc Lung Dis 2022;26:174-6. [PMID: 35086632 DOI: 10.5588/ijtld.21.0628] [Reference Citation Analysis]
18 Marquês JT, Frazão De Faria C, Reis M, Machado D, Santos S, Santos MDS, Viveiros M, Martins F, De Almeida RFM. In vitro Evaluation of Isoniazid Derivatives as Potential Agents Against Drug-Resistant Tuberculosis. Front Pharmacol 2022;13:868545. [DOI: 10.3389/fphar.2022.868545] [Reference Citation Analysis]
19 Migliori GB, Thong PM, Alffenaar JW, Denholm J, Tadolini M, Alyaquobi F, Blanc FX, Buonsenso D, Cho JG, Ruffo Codecasa L, Danila E, Duarte R, García-García JM, Gualano G, Rendon A, Rossato Silva D, Souleymane MB, Tham SM, Thomas TA, Tiberi S, Udwadia ZF, Goletti D, Centis R, D'Ambrosio L, Sotgiu G, Ong CWM; Global Tuberculosis Network. Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study. Eur Respir J 2021:2101786. [PMID: 34446465 DOI: 10.1183/13993003.01786-2021] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Thaden JT, Maskarinec SA. When two for the price of one isn't a bargain: estimating prevalence and microbiology of bacterial co-infections in patients with COVID-19. Clin Microbiol Infect 2020;26:1602-3. [PMID: 32919069 DOI: 10.1016/j.cmi.2020.09.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
21 Petrone L, Petruccioli E, Alonzi T, Vanini V, Cuzzi G, Najafi Fard S, Castilletti C, Palmieri F, Gualano G, Vittozzi P, Nicastri E, Lepore L, Grifoni A, Antinori A, Vergori A, Ippolito G, Cantini F, Goletti D. In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy. J Infect 2021;82:58-66. [PMID: 33639176 DOI: 10.1016/j.jinf.2021.02.023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
22 Khanum I, Kumar L, Awan S, Jamil B. Severity of COVID-19 in bacillus Calmette-Guérin vaccinated population. Clin Exp Vaccine Res 2021;10:276-81. [PMID: 34703811 DOI: 10.7774/cevr.2021.10.3.276] [Reference Citation Analysis]
23 Petrone L, Petruccioli E, Vanini V, Cuzzi G, Gualano G, Vittozzi P, Nicastri E, Maffongelli G, Grifoni A, Sette A, Ippolito G, Migliori GB, Palmieri F, Goletti D. Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2. Int J Infect Dis 2021:S1201-9712(21)00176-4. [PMID: 33713816 DOI: 10.1016/j.ijid.2021.02.090] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
24 Behera D. Tuberculosis, COVID-19, and the End Tuberculosis strategy in India. Lung India 2020;37:467-72. [PMID: 33154206 DOI: 10.4103/lungindia.lungindia_544_20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
25 Rajasekhar S, Das S, Karuppasamy R, Musuvathi Motilal B, Chanda K. Identification of novel inhibitors for Prp protein of Mycobacterium tuberculosis by structure based drug design, and molecular dynamics simulations. J Comput Chem 2022;43:619-30. [PMID: 35167132 DOI: 10.1002/jcc.26823] [Reference Citation Analysis]
26 Lommatzsch M, Rabe KF, Taube C, Joest M, Kreuter M, Wirtz H, Blum TG, Kolditz M, Geerdes-Fenge H, Otto-Knapp R, Häcker B, Schaberg T, Ringshausen FC, Vogelmeier CF, Reinmuth N, Reck M, Gottlieb J, Konstantinides S, Meyer FJ, Worth H, Windisch W, Welte T, Bauer T. [Risk Assessment for Patients with Chronic Respiratory and Pulmonary Conditions in the Context of the SARS-CoV-2 Pandemic - Statement of the German Respiratory Society (DGP) with the Support of the German Association of Respiratory Physicians (BdP)]. Pneumologie 2021;75:19-30. [PMID: 33242887 DOI: 10.1055/a-1321-3400] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
27 Lommatzsch M, Rabe KF, Taube C, Joest M, Kreuter M, Wirtz H, Blum TG, Kolditz M, Geerdes-fenge H, Otto-knapp R, Häcker B, Schaberg T, Ringshausen FC, Vogelmeier CF, Reinmuth N, Reck M, Gottlieb J, Konstantinides S, Meyer J, Worth H, Windisch W, Welte T, Bauer T. Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians. Respiration 2022;101:307-20. [DOI: 10.1159/000518896] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Silva DR, Mello FCQ, D'Ambrosio L, Centis R, Dalcolmo MP, Migliori GB. Tuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe? J Bras Pneumol 2021;47:e20210044. [PMID: 33950095 DOI: 10.36416/1806-3756/e20210044] [Reference Citation Analysis]
29 Castellarnau A, Heery GP, Seta A, Luscombe CA, Kinghorn GR, Button P, McCloud P, Paull JRA. Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial. Sci Rep 2022;12:10210. [PMID: 35715644 DOI: 10.1038/s41598-022-14601-3] [Reference Citation Analysis]
30 Tsolaki AG, Varghese PM, Kishore U. Innate Immune Pattern Recognition Receptors of Mycobacterium tuberculosis: Nature and Consequences for Pathogenesis of Tuberculosis. Adv Exp Med Biol 2021;1313:179-215. [PMID: 34661896 DOI: 10.1007/978-3-030-67452-6_9] [Reference Citation Analysis]
31 Sentís A, Prats-Uribe A, Peixoto VR, Caylà JA, Gomes MD, Sousa S, Duarte R, Carvalho I, Carvalho C. Decline of tuberculosis notification rate in different populations and regions in Portugal, 2010-2017. Pulmonology 2021:S2531-0437(21)00158-6. [PMID: 34544672 DOI: 10.1016/j.pulmoe.2021.08.002] [Reference Citation Analysis]
32 Seyran M. Artificial intelligence and clinical data suggest the T cell-mediated SARS-CoV-2 nonstructural protein intranasal vaccines for global COVID-19 immunity. Vaccine 2022:S0264-410X(22)00821-0. [PMID: 35778279 DOI: 10.1016/j.vaccine.2022.06.052] [Reference Citation Analysis]
33 Petrone L, Tamarozzi F, Vola A, Gomez Morales MA, Ludovisi A, Najafi Fard S, Mariconti M, Brunetti E, Goletti D. Accuracy of an experimental whole-blood test for detecting reactivation of echinococcal cysts. PLoS Negl Trop Dis 2021;15:e0009648. [PMID: 34415898 DOI: 10.1371/journal.pntd.0009648] [Reference Citation Analysis]
34 TB/COVID-19 Global Study Group. Tuberculosis and COVID-19 co-infection: description of the global cohort. Eur Respir J 2021:2102538. [PMID: 34764184 DOI: 10.1183/13993003.02538-2021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Behera D. TB control in India in the COVID era. Indian J Tuberc 2021;68:128-33. [PMID: 33641833 DOI: 10.1016/j.ijtb.2020.08.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
36 Duarte R, Aguiar A, Pinto M, Furtado I, Tiberi S, Lönnroth K, Migliori GB. Different disease, same challenges: Social determinants of tuberculosis and COVID-19. Pulmonology 2021;27:338-44. [PMID: 33648891 DOI: 10.1016/j.pulmoe.2021.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
37 Visca D, Ong CWM, Tiberi S, Centis R, D'Ambrosio L, Chen B, Mueller J, Mueller P, Duarte R, Dalcolmo M, Sotgiu G, Migliori GB, Goletti D. Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects. Pulmonology 2021;27:151-65. [PMID: 33547029 DOI: 10.1016/j.pulmoe.2020.12.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
38 Rivas N, Espinoza M, Loban A, Luque O, Jurado J, Henry-Hurtado N, Goodridge A. Case Report: COVID-19 Recovery from Triple Infection with Mycobacterium tuberculosis, HIV, and SARS-CoV-2. Am J Trop Med Hyg 2020;103:1597-9. [PMID: 32815513 DOI: 10.4269/ajtmh.20-0756] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
39 Di Gennaro F, Gualano G, Timelli L, Vittozzi P, Di Bari V, Libertone R, Cerva C, Pinnarelli L, Nisii C, Ianniello S, Mosti S, Bevilacqua N, Iacomi F, Mondi A, Topino S, Goletti D, Vaia F, Ippolito G, Girardi E, Palmieri F. Increase in Tuberculosis Diagnostic Delay during First Wave of the COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital. Antibiotics (Basel) 2021;10:272. [PMID: 33800406 DOI: 10.3390/antibiotics10030272] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
40 Santos FLD, Souza LLL, Bruce ATI, Crispim JA, Arroyo LH, Ramos ACV, Berra TZ, Alves YM, Scholze AR, Costa FBPD, Martoreli Júnior JF, Moncaio ACS, Pinto IC, Arcêncio RA. Patients' perceptions regarding multidrug-resistant tuberculosis and barriers to seeking care in a priority city in Brazil during COVID-19 pandemic: A qualitative study. PLoS One 2021;16:e0249822. [PMID: 33836024 DOI: 10.1371/journal.pone.0249822] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Tiberi S, Vjecha MJ, Zumla A, Galvin J, Migliori GB, Zumla A. Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic. Int J Infect Dis 2021:S1201-9712(21)00153-3. [PMID: 33713815 DOI: 10.1016/j.ijid.2021.02.067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
42 do Couto AC, Kmetiuk LB, Delai RR, Brandão APD, Monteiro CO, da Silva LHA, Soares C, Banari AC, Bach RVW, Pettan-Brewer C, Dos Santos AP, Guimarães AMS, Oliveira DBL, Durigon EL, Biondo AW. High SARS-CoV-2 seroprevalence in persons experiencing homelessness and shelter workers from a day-shelter in São Paulo, Brazil. PLoS Negl Trop Dis 2021;15:e0009754. [PMID: 34665803 DOI: 10.1371/journal.pntd.0009754] [Reference Citation Analysis]
43 Gupta N, Ish P, Gupta A, Malhotra N, Caminero JA, Singla R, Kumar R, Yadav SR, Dev N, Agrawal S, Kohli S, Sen MK, Chakrabarti S, Gupta NK. A profile of a retrospective cohort of 22 patients with COVID-19 and active/treated tuberculosis. Eur Respir J 2020;56:2003408. [PMID: 33093125 DOI: 10.1183/13993003.03408-2020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
44 Migliori GB, Thong PM, Akkerman O, Alffenaar JW, Álvarez-Navascués F, Assao-Neino MM, Bernard PV, Biala JS, Blanc FX, Bogorodskaya EM, Borisov S, Buonsenso D, Calnan M, Castellotti PF, Centis R, Chakaya JM, Cho JG, Codecasa LR, D'Ambrosio L, Denholm J, Enwerem M, Ferrarese M, Galvão T, García-Clemente M, García-García JM, Gualano G, Gullón-Blanco JA, Inwentarz S, Ippolito G, Kunst H, Maryandyshev A, Melazzini M, de Queiroz Mello FC, Muñoz-Torrico M, Njungfiyini PB, Palmero DJ, Palmieri F, Piccioni P, Piubello A, Rendon A, Sabriá J, Saporiti M, Scognamiglio P, Sharma S, Silva DR, Souleymane MB, Spanevello A, Tabernero E, Tadolini M, Tchangou ME, Thornton ABY, Tiberi S, Udwadia ZF, Sotgiu G, Ong CWM, Goletti D. Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020. Emerg Infect Dis 2020;26:2709-12. [PMID: 32917293 DOI: 10.3201/eid2611.203163] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 15.0] [Reference Citation Analysis]
45 Mousquer GT, Peres A, Fiegenbaum M. Pathology of TB/COVID-19 Co-Infection: The phantom menace. Tuberculosis (Edinb) 2021;126:102020. [PMID: 33246269 DOI: 10.1016/j.tube.2020.102020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
46 Lau LHW, Wong NS, Leung CC, Chan CK, Lau AKH, Tian L, Lee SS. Seasonality of tuberculosis in intermediate endemicity setting dominated by reactivation diseases in Hong Kong. Sci Rep 2021;11:20259. [PMID: 34642391 DOI: 10.1038/s41598-021-99651-9] [Reference Citation Analysis]
47 Angulo C, Sanchez V, Delgado K, Monreal-Escalante E, Hernández-Adame L, Angulo M, Tello-Olea M, Reyes-Becerril M. Oral organic nanovaccines against bacterial and viral diseases. Microb Pathog 2022;169:105648. [PMID: 35728750 DOI: 10.1016/j.micpath.2022.105648] [Reference Citation Analysis]